Hereditary Angioedema Pipeline, Clinical and Non-Clinical Products and FDA Approvals 2023 (Updated)
DelveInsights, Hereditary Angioedema Pipeline Insight 2023 report provides comprehensive insights about 20+ companies and 30+ pipeline drugs in the Hereditary Angioedema pipeline landscape. It...
United States Yash Bhardwaj Las Vegas Hereditary Angioedema Biocryst Pharmaceuticals Kalvista Pharmaceuticals Mid Stage Products Phase Company Name Inactive Products Hereditary
Source: marketscreener.com